These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6085238)

  • 1. The role of diuretics and inotropic therapy in failure associated with myocardial infarction.
    Roberts R
    Arch Int Physiol Biochim; 1984 Nov; 92(4):S33-48. PubMed ID: 6085238
    [No Abstract]   [Full Text] [Related]  

  • 2. Inotropic therapy for cardiac failure associated with acute myocardial infarction.
    Roberts R
    Chest; 1988 Jan; 93(1 Suppl):22S-24S. PubMed ID: 3335175
    [No Abstract]   [Full Text] [Related]  

  • 3. Tailored therapy to hemodynamic goals for advanced heart failure.
    Stevenson LW
    Eur J Heart Fail; 1999 Aug; 1(3):251-7. PubMed ID: 10935671
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of digoxin and dobutamine in patients with acute infarction and cardiac failure.
    Goldstein RA; Passamani ER; Roberts R
    N Engl J Med; 1980 Oct; 303(15):846-50. PubMed ID: 7412802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy of short-term intravenous infusions of milrinone and dobutamine in acute congestive heart failure following acute myocardial infarction. Milrinone-Dobutamine Study Group.
    Karlsberg RP; DeWood MA; DeMaria AN; Berk MR; Lasher KP
    Clin Cardiol; 1996 Jan; 19(1):21-30. PubMed ID: 8903534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct modulation of myocardial performance, energy metabolism, and [Ca2+]i transients by positive inotropic drugs in normal and severely failing hamster hearts.
    Buser PT; Wu SY; Parmley WW; Jasmin G; Wikman-Coffelt J
    Cardiovasc Drugs Ther; 1995 Feb; 9(1):151-7. PubMed ID: 7786836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined therapy with digoxin and nitroprusside in heart failure complicating acute myocardial infarction.
    Raabe DS
    Am J Cardiol; 1979 May; 43(5):990-4. PubMed ID: 433783
    [No Abstract]   [Full Text] [Related]  

  • 8. [Heart failure and acute myocardial infarct. Current treatment].
    Bernard R; Renard M
    Bull Mem Acad R Med Belg; 1983; 138(11):534-43. PubMed ID: 6679446
    [No Abstract]   [Full Text] [Related]  

  • 9. Myocardial Na,K-ATPase: the molecular basis for the hemodynamic effect of digoxin therapy in congestive heart failure.
    Kjeldsen K; Nørgaard A; Gheorghiade M
    Cardiovasc Res; 2002 Sep; 55(4):710-3. PubMed ID: 12176120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of inotropic therapy by venodilation in acute heart failure: a randomised comparison of four inotropic agents, alone and combined with isosorbide dinitrate.
    Verma SP; Silke B; Reynolds GW; Richmond A; Taylor SH
    J Cardiovasc Pharmacol; 1992 Jan; 19(1):24-33. PubMed ID: 1375684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical issues in the management of heart failure.
    Boccanelli A; Scardovi AB
    G Ital Cardiol; 1999 Oct; 29(10):1195-8. PubMed ID: 10546133
    [No Abstract]   [Full Text] [Related]  

  • 12. General overview and update of positive inotropic therapy.
    Leier CV
    Am J Med; 1986 Oct; 81(4C):40-5. PubMed ID: 2946223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemodynamic advantages of a combined inotropic/venodilator regimen over inotropic monotherapy in acute heart failure.
    Verma SP; Silke B; Nelson GI; Hussain M; Richmond A; Taylor SH
    J Cardiovasc Pharmacol; 1985; 7(5):943-7. PubMed ID: 2413305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of heart failure in children].
    Pipitone S; Manetti A
    G Ital Cardiol; 1995 Nov; 25(11):1485-90. PubMed ID: 8682250
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemodynamic effects of dobutamine in patients below and over 65 years, with left heart failure secondary to an acute myocardial infarction.
    Renard M; Bernard R; Melot C; Jacobs P; Englert M
    Gerontology; 1984; 30(6):408-13. PubMed ID: 6519441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Application of non-glycoside inotropic agents in newborn infants].
    Umans-Eckenhausen MA; Terlouw JF; Szatmari A; van den Anker JN
    Tijdschr Kindergeneeskd; 1993 Feb; 61(1):13-20. PubMed ID: 8493697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is inotropic therapy appropriate for patients with chronic congestive heart failure? Or is the digitalis leaf withering?
    Uretsky BF
    Postgrad Med J; 1986 Jun; 62(728):585-92. PubMed ID: 2946034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular failure complicating acute myocardial infarction--problems and potential of nonthrombolytic therapy.
    Taylor SH
    Cardiology; 1988; 75 Suppl 1():67-89. PubMed ID: 3069218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of nonglycosidic inotropic agents: indications, ethics, and limitations.
    Chatterjee K; De Marco T
    Med Clin North Am; 2003 Mar; 87(2):391-418. PubMed ID: 12693731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of digitalis on hemodynamics in acute myocardial infarct. II. Myocardial infarct associated with acute severe insufficiency of the left heart and cardiogenic shock].
    Schüren KP; Ramdohr B; Dissmann W; Buschmann HJ; Schröder R
    Klin Wochenschr; 1970 May; 48(10):591-7. PubMed ID: 5517327
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.